Baslund B, Szpirt W, Eriksson S, Elzouki A N, Wiik A, Wieslander J, Petersen J
Department of Autoimmunology, Statens Seruminstitut, Copenhagen, Denmark.
Eur J Clin Invest. 1996 Sep;26(9):786-92. doi: 10.1046/j.1365-2362.1996.2070553.x.
To test the hypothesis that anti-neutrophil cytoplasm autoantibodies (ANCAs) interfere with the functions of proteinase 3 (PR3) (the Wegener autoantigen) and alpha 1-antitrypsin (alpha 1AT), complexes of PR3/alpha 1 AT and PR3/PR3-ANCA-IgG were assayed Plasma samples were obtained from 44 patients with Wegener's granulomatosis (WG): 34 had active disease (88% ANCA positive) whereas 10 patients were in remission (20% ANCA positive). Plasma samples from 14 of the patients with active disease were also available at the time of remission. The complexes of PR3/alpha 1 AT and PR3/PR3-ANCA-IgG were detected by capture enzyme-linked immunoassays (ELISAs) alpha 1 AT deficiency was evaluated by determining PiZ alleles by ELISA. Eight (18%) of the patients were PiZ positive. The frequency of this alpha 1-antitrypsin phenotype in the Scandinavian population is 4.7% (P < 0.001). The median PR3/alpha 1AT complex level in the PiZ-positive group with active disease (n = 5) was similar to the level in the PiZ-negative group with active disease. During remission the median level for the PR3/alpha 1AT complex was significantly higher than in the acute group (P < 0.001) including both PiZ-positive and PiZ-negative patients. No difference between PiZ positivity and PiZ negativity could be found in the remission group. PR3/PR3-ANCA-IgG complexes were found in patients with acute disease as well as in patients in remission, in almost equal frequency. This complex was also present in 13/18 ANCA-negative samples from patients in remission. Finally, purified IgG fractions from WG patients were examined for their capacity to inhibit binding between PR3 and alpha 1AT. An effect on the binding between PR3 and alpha 1AT by PR3-ANCA could not be demonstrated. Thus, our results do not support the hypothesis that PR3-ANCA interferes with the binding between PR3 and alpha 1AT. However, the high prevalence of the PiZ alleles among WG patients suggests that an imbalance between proteinases and alpha 1AT may be of importance in this disease. The clinical usefulness of both the PR3/alpha 1AT and the PR3/PR3-ANCA-IgG complexes and the possible influence on ANCA detection need to be examined in prospective longitudinal studies.
为验证抗中性粒细胞胞浆自身抗体(ANCA)干扰蛋白酶3(PR3)(韦格纳自身抗原)和α1抗胰蛋白酶(α1AT)功能这一假说,对PR3/α1AT和PR3/PR3-ANCA-IgG复合物进行了检测。从44例韦格纳肉芽肿病(WG)患者获取血浆样本:34例患有活动性疾病(88%ANCA阳性),而10例患者处于缓解期(20%ANCA阳性)。14例活动性疾病患者在缓解期时的血浆样本也可获取。通过捕获酶联免疫吸附测定(ELISA)检测PR3/α1AT和PR3/PR3-ANCA-IgG复合物。通过ELISA测定PiZ等位基因来评估α1AT缺乏情况。8例(18%)患者PiZ阳性。斯堪的纳维亚人群中这种α1抗胰蛋白酶表型的频率为4.7%(P<0.001)。PiZ阳性且患有活动性疾病组(n=5)的PR3/α1AT复合物水平中位数与PiZ阴性且患有活动性疾病组相似。缓解期PR3/α1AT复合物水平中位数显著高于急性期组(P<0.001),包括PiZ阳性和PiZ阴性患者。缓解期组中PiZ阳性和PiZ阴性之间未发现差异。PR3/PR3-ANCA-IgG复合物在急性期患者以及缓解期患者中均有发现,频率几乎相同。该复合物在13/18例缓解期患者的ANCA阴性样本中也存在。最后检查了WG患者纯化的IgG组分抑制PR3与α1AT结合的能力。未证实PR3-ANCA对PR3与α1AT结合有影响。因此,我们的结果不支持PR3-ANCA干扰PR3与α1AT结合这一假说。然而,WG患者中PiZ等位基因的高患病率表明蛋白酶与α1AT之间的失衡可能在该疾病中具有重要意义。PR3/α1AT和PR3/PR3-ANCA-IgG复合物的临床实用性以及对ANCA检测的可能影响需要在前瞻性纵向研究中进行检查。